TY - JOUR
T1 - Solution structure of native proteins with irregular folds from Raman optical activity
AU - Smyth, Edward
AU - Syme, Christopher D.
AU - Blanch, Ewan W.
AU - Hecht, Lutz
AU - Vaák, Milan
AU - Barron, Laurence D.
PY - 2001
Y1 - 2001
N2 - Raman optical activity (ROA) spectra have been measured for the proteins hen phosvitin, yeast invertase, bovine α-casein, soybean Bowman-Birk protease inhibitor, and rabbit Cd7-metallothionein, all of which have irregular folds in the native state. The results show that ROA is able to distinguish between two types of disorder. Specifically, invertase, α-casein, the Bowman-Birk inhibitor, and metallothionein appear to possess a "static" type of disorder similar to that in disordered states of poly(L-lysine) and poly(L-glutamic acid); whereas phosvitin appears to possess a more "dynamic" type of disorder similar to that in reduced (unfolded) lysozyme and ribonuclease A and also in molten globule protein states. In the delimiting cases, static disorder corresponds to that found in loops and turns within native proteins with well-defined tertiary folds that contain sequences of residues with fixed but nonrepetitive Φ, Ψ angles; and dynamic disorder corresponds to that envisaged for the model random coil in which there is a distribution of Ramachandran Φ, Ψ angles for each amino acid residue, giving rise to an ensemble of interconverting conformers. In both cases there is a propensity for the Φ, Ψ angles to correspond to the α, β and poly(L-proline) II (PPII) regions of the Ramachandran surface, as in native proteins with well-defined tertiary folds. Our results suggest that, with the exception of invertase and metallothionein, an important conformational element present in the polypeptide and protein states supporting the static type of disorder is that of the PPII helix. Long sequences of relatively unconstrained PPII helix, as in α-casein, may impart a plastic (rheomorphic) character to the structure. © 2001 John Wiley & Sons, Inc.
AB - Raman optical activity (ROA) spectra have been measured for the proteins hen phosvitin, yeast invertase, bovine α-casein, soybean Bowman-Birk protease inhibitor, and rabbit Cd7-metallothionein, all of which have irregular folds in the native state. The results show that ROA is able to distinguish between two types of disorder. Specifically, invertase, α-casein, the Bowman-Birk inhibitor, and metallothionein appear to possess a "static" type of disorder similar to that in disordered states of poly(L-lysine) and poly(L-glutamic acid); whereas phosvitin appears to possess a more "dynamic" type of disorder similar to that in reduced (unfolded) lysozyme and ribonuclease A and also in molten globule protein states. In the delimiting cases, static disorder corresponds to that found in loops and turns within native proteins with well-defined tertiary folds that contain sequences of residues with fixed but nonrepetitive Φ, Ψ angles; and dynamic disorder corresponds to that envisaged for the model random coil in which there is a distribution of Ramachandran Φ, Ψ angles for each amino acid residue, giving rise to an ensemble of interconverting conformers. In both cases there is a propensity for the Φ, Ψ angles to correspond to the α, β and poly(L-proline) II (PPII) regions of the Ramachandran surface, as in native proteins with well-defined tertiary folds. Our results suggest that, with the exception of invertase and metallothionein, an important conformational element present in the polypeptide and protein states supporting the static type of disorder is that of the PPII helix. Long sequences of relatively unconstrained PPII helix, as in α-casein, may impart a plastic (rheomorphic) character to the structure. © 2001 John Wiley & Sons, Inc.
KW - Disordered polypeptides
KW - Disordered proteins
KW - Poly(L-proline) II helix
KW - Protein loop structure
KW - Raman optical activity
KW - Vibrational optical activity
UR - https://www.scopus.com/pages/publications/0035144719
U2 - 10.1002/1097-0282(200102)58:2<138::AID-BIP30>3.0.CO;2-W
DO - 10.1002/1097-0282(200102)58:2<138::AID-BIP30>3.0.CO;2-W
M3 - Article
C2 - 11093113
SN - 0006-3525
VL - 58
SP - 138
EP - 151
JO - Biopolymers
JF - Biopolymers
IS - 2
ER -